ABG-WTT Global Life Science Capital Partners GP Ltd — Q1 2026 13F-HR

← ABG-WTT Global Life Science Capital Partners GP Ltd

Q1 2026 · 13F-HR

ABG-WTT Global Life Science Capital Partners GP Ltdholdings as filed

Filed 2026-05-18 · accession 0001193125-26-227557

$12.3M

Reported value

Positions

2026-03-31

Period end

View analyzed profile →PRO

The Brief · ABG-WTT Global Life Science Capital Partners GP Ltd · Q1 2026

AI · grounded in 13F

ABG-WTT Global Life Science Capital Partners GP Ltd reported no changes to its 13F holdings for 2026-03-31 relative to 2025-12-31.

Holdings as filed

CUSIP	Ticker	Issuer	Value	% port.	Shares	Class	Voting
15678C102	CBLL	CERIBELL INC	$8.1M	65.9%	441,820	Common	SOLE
75340L104	RPID	RAPID MICRO BIOSYSTEMS INC	$4.2M	34.1%	1,848,296	Common	SOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.